CCL20 and breast carcinoma: Further, the osteoblastic cells produced CCL20 (Fig. 6d), and the antibody-mediated neutralization of osteoblastic cell-derived CCL20 significantly inhibited the invasiveness of MDA-MB-231 breast cancer cells (Fig. 6e).